Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Perry

Showing results (201-210 of 219) with videos related to

Pageof 22
Sort By:
Brain Research. Developmental Brain Research|July 18, 1997
Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and agingJ A Court, S Lloyd, M Johnson, et al.
Pharmacogenetics|April 20, 1999
CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's diseaseA Atkinson, A B Singleton, A Steward, et al.
Neurology|February 11, 2000
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in ADA M Gibson, A B Singleton, G Smith, et al.
Pharmacology, Biochemistry, and Behavior|February 14, 2002
Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodiesJ A Court, C G Ballard, M A Piggott, et al.
Neurology|July 26, 2000
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodiesP F Chinnery, G A Taylor, N Howell, et al.
Novartis Foundation Symposium|March 31, 2001
Multiple substrates of late-onset dementia: implications for brain protectionR N Kalaria, C G Ballard, P G Ince, et al.
Experimental Neurology|January 15, 2005
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamusI J Bohr, M A Ray, J M McIntosh, et al.
Brain : a Journal of Neurology|August 4, 1999
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distributionM A Piggott, E F Marshall, N Thomas, et al.
Biological Psychiatry|November 3, 1998
Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's diseaseM A Piggott, E K Perry, E F Marshall, et al.
Neuropathology and Applied Neurobiology|August 13, 2004
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brainM S Fernando, J T O'Brien, R H Perry, et al.
Pageof 22

Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Brain Research. Developmental Brain Research|July 18, 1997
Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and agingJ A Court, S Lloyd, M Johnson, et al.
Pharmacogenetics|April 20, 1999
CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's diseaseA Atkinson, A B Singleton, A Steward, et al.
Neurology|February 11, 2000
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in ADA M Gibson, A B Singleton, G Smith, et al.
Pharmacology, Biochemistry, and Behavior|February 14, 2002
Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodiesJ A Court, C G Ballard, M A Piggott, et al.
Neurology|July 26, 2000
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodiesP F Chinnery, G A Taylor, N Howell, et al.
Novartis Foundation Symposium|March 31, 2001
Multiple substrates of late-onset dementia: implications for brain protectionR N Kalaria, C G Ballard, P G Ince, et al.
Experimental Neurology|January 15, 2005
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamusI J Bohr, M A Ray, J M McIntosh, et al.
Brain : a Journal of Neurology|August 4, 1999
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distributionM A Piggott, E F Marshall, N Thomas, et al.
Biological Psychiatry|November 3, 1998
Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's diseaseM A Piggott, E K Perry, E F Marshall, et al.
Neuropathology and Applied Neurobiology|August 13, 2004
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brainM S Fernando, J T O'Brien, R H Perry, et al.
Pageof 22